GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » Quick Ratio

AroCell AB (OSTO:AROC) Quick Ratio : 5.25 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. AroCell AB's quick ratio for the quarter that ended in Dec. 2023 was 5.25.

AroCell AB has a quick ratio of 5.25. It generally indicates good short-term financial strength.

The historical rank and industry rank for AroCell AB's Quick Ratio or its related term are showing as below:

OSTO:AROC' s Quick Ratio Range Over the Past 10 Years
Min: 1.34   Med: 6.72   Max: 31.3
Current: 5.25

During the past 13 years, AroCell AB's highest Quick Ratio was 31.30. The lowest was 1.34. And the median was 6.72.

OSTO:AROC's Quick Ratio is ranked better than
84.75% of 236 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.91 vs OSTO:AROC: 5.25

AroCell AB Quick Ratio Historical Data

The historical data trend for AroCell AB's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AroCell AB Quick Ratio Chart

AroCell AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.34 10.16 2.48 5.70 5.25

AroCell AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.70 5.94 5.94 5.82 5.25

Competitive Comparison of AroCell AB's Quick Ratio

For the Diagnostics & Research subindustry, AroCell AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AroCell AB's Quick Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, AroCell AB's Quick Ratio distribution charts can be found below:

* The bar in red indicates where AroCell AB's Quick Ratio falls into.



AroCell AB Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

AroCell AB's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(65.1-6.071)/11.246
=5.25

AroCell AB's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(65.1-6.071)/11.246
=5.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB  (OSTO:AROC) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


AroCell AB Quick Ratio Related Terms

Thank you for viewing the detailed overview of AroCell AB's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB (OSTO:AROC) Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings allé 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

AroCell AB (OSTO:AROC) Headlines

From GuruFocus

Archrock Publishes its 2021 Annual Sustainability Report

By PurpleRose PurpleRose 08-11-2022

Archrock Announces Timing for First Quarter 2023 Results

By sperokesalga sperokesalga 04-25-2023

Archrock Announces Quarterly Cash Dividend

By PurpleRose PurpleRose 07-28-2022

Archrock Announces Quarterly Cash Dividend

By Marketwired Marketwired 10-28-2021

Archrock (AROC): A Deep Dive into Its Overvaluation

By GuruFocus Research 09-27-2023

Archrock Announces Quarterly Cash Dividend

By Marketwired 10-26-2023

Archrock Announces Timing for Fourth Quarter 2022 Results

By sperokesalga sperokesalga 02-13-2023